Li Lab: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
(286 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{Template:Li Lab}}
{{Template:Li_Lab}}


<div style=" width: 1024px; padding: .1em 1.5em .9em">
<center>
{| cellspacing="0"
{| cellspacing="5px"
|- valign="top"
| width="60%" align="justify" style="border: 2px solid #6688aa; background-color:#cccccc; padding:1em;" class="plainlinks"|
|width="70%" style="border: 1px solid #dddddd; color: #000; background-color: #dddddd"|
<div style="float:left;margin-left:0.3em;margin-right:0.7em">
<div style="padding: left; text-align: left; float: left; ">


Our lab is focused on the design and application of statistical and computational algorithms to elucidate global transcription regulatory mechanism.
== '''Computational Epigenomics and Transcriptomics Lab (PI: Wei Li)''' ==


An elaborate system of transcription regulation is responsible for the morphological and behavioral complexity in higher eukaryotes. This regulatory system consists of diverse trans-acting protein factors and cis-acting regulatory DNA sequences. Recently, Chromatin ImmunoPrecipitation coupled with whole genome tiled microarray (ChIP-chip) and/or next-generation sequencing (Solexa, SOLid and 454) has evolved as a powerful and unbiased technique to study genome-wide in vivo binding of the trans-acting protein factors. The application of this technology to multiple factors and/or in multiple conditions allows biologists to study how trans-factors differentially regulate transcription in a combinatorial manner. However, it also poses great challenges for the development of effective algorithms, the key link between massive raw data and biological hypotheses.
[http://www.bcm.edu/cancercenter/ Dan L. Duncan Cancer Center], [http://www.bcm.edu/mcb/index.html Department of Molecular and Cellular Biology], [http://www.bcm.edu/ Baylor College of Medicine]


We developed a series of algorithms to reliably detect and annotate ChIP-enriched regions using Affymetrix whole-genome tiling arrays, including 1) Model-based Analysis of Tiling-arrays (MAT; PNAS 2006) and a hidden Markov model (Bioinformatics 2005) for ChIP-region detection, 2) extreme MApping of OligoNucleotide (xMAN, BMC Genomics 2007) for microarray probe mapping, 3) Cis-regulatory Element Annotation System (CEAS; NAR 2006) for ChIP-region annotation. Since the inception in early 2006, they have been adopted by hundreds of academic users and are now considered as the ChIP-chip data analysis standard in many labs. We are also working with the ENCODE spike-in consortium, which consists of more than 10 transcriptional regulation groups worldwide, to systematically analyze the performance variability introduced in ChIP-chip protocols, array platforms, and analysis methods.
</div>
 
We are also in close collaboration with several labs on identifying global regulation targets of a series of key transcription factors, including estrogen receptor (Cell 2005; Nature Genetics 2006); androgen receptor (Molecular Cell 2007); STAT5 (J. Biological Chemistry 2006); TAL1 (Blood 2006); and p53 (Bioinformatics 2005).
| rowspan="2" width="40%" style="border: 2px dashed #6688AA; background-color:#ffffff; padding:1em;" valign="top"|
 
==Recent News==
. 06/2014:  Deqiang's Dnmt3a/3b double KO paper (with the Goodell Lab) is accepted to '''Cell Stem Cell '''.
 
. 06/2014: Zheng's alternative splicing paper (with the Cooper Lab) is accepted to '''Molecular Cell '''.
 
. 04/2014:  Liguo's ChIP-exo methodology paper (MACE) is accepted in principle in '''Nucleic Acids Research'''.
 
. 02/2014:  DQ and HJ's HSC LncRNA paper (with the Goodell Lab) is in revision in '''Cell Stem Cell'''.
 
. 02/2014:  Zheng's collaborative work on alternative splicing in heart development is accepted to '''Nature Communications'''.
 
. 02/2014:  Zheng's brain tumor 3'UTR regulator paper is accepted to '''Nature'''. This paper was initially rejected after review twice. We appealed twice with success and finally made it in the 3rd submission.
 
. 02/2014:  Welcome our new postdoc Jianzhong Su and graduate student Xueqiu Lin.
 
. 02/2014:  Deqiang's mouse HSC Aging Epigenomics paper is accepted in principle to '''Cell Stem Cell'''.
 
. 01/2014:  Deqiang's Methodology paper for the detection of differential DNA Methylation (MOABS) is accepted to '''Genome Biology'''.
 
. 01/2014:  Our collaborative work on Breast Cancer Epigenetics is accepted to '''Science Translational Medicine'''.
 
. 01/2014:  Yuanxin and Zheng's ZM11 paper with Xiaobing Shi lab in MD Anderson is accepted to '''Nature'''. This work links transcription elongation to tumor suppression.
 
. 12/2013: Kaifu's aging nucleosome paper is accepted to ''' Genes & Development'''
 
. 12/2013: We received a 5-year NIH/NHGRI '''R01''' grant (scored at 6 percentile in its first submission) to study DNA Methylation
 
. 11/2013: Wei will serve on the Editorial Board of '''Molecular Endocrinology'''
 
. 09/2013:  Deqiang's DNA methylation Canyon paper is accepted to '''Nature Genetics'''.
 
. 09/2013:  Xueqiu's bisulfite sequencing quality control paper (BSeQC) is accepted to '''Bioinformatics'''.
 
. 08/2013:  Kadir's p53 paper is accepted to '''Nucleic Acids Research'''
 
. 06/2013:  Zheng's TCGA RNA-seq bioinformatics paper is under review in '''Nature Biotechnology'''.
 
. 01/2013:  [http://www.bcm.edu/news/item.cfm?newsID=6723 BCM News] and  [http://epigenie.com/danpos-reveals-dynamic-nucleosomes Epigenie Headline] about our recent work on nucleosome dynamics.
 
. 12/2012:  Liguo and HJ's CPAT RNA coding potential prediction paper is accepted to '''Nucleic Acids Research'''.
 
. 11/2012:  Kaifu's nucleosome methodology paper DANPOS is accepted to '''Genome Research'''.
 
. 10/2012:  Kaifu's promoter nucleosome paper is accepted to '''Genome Research'''.
 
. 09/2012:  A '''NIH R01 grant''' was funded. We will work with Dr. Issa at Temple Univ. to understand DNA methylation in Cancer.
 
. 08/2012: A mouse ES nucleosome paper from Kaestner lab at Upenn is accepted to '''Cell'''. Kaifu and Wei used DANPOS to analyze the data and were listed as co-authors.
 
. 08/2012: Dr. Benjamin Rodriguez will join us as a '''Postdoc Associate'''. Ben has PhD in Integrated Biomedical Science from the Ohio State Univ. Welcome!
 
. 08/2012:  A '''Mazzone Award ''' is funded. We will work with Dr. Balk at Harvard Medical School to understand the molecular features of aggressive prostate cancer.
. 06/2012: Liguo's RNA-seq Quality Control paper is accepted to '''Bioinformatics'''.
 
. 06/2012:  A '''NIH R01 grant''' is funded. We will work with Dr. Goodell at BCM to understand DNA methylation in Hematopoietic Stem Cell.
 
. 04/2012:  A '''NIH R01 grant''' is funded. We will work with Dr. Dent at MD Anderson to define USP22 functions during mammalian development.
 
. 04/2012:  Dr.Dean Tang's prostate cancer stem cell paper is accepted in '''Cell Stem Cell'''. Wei is a co-author.
 
. 02/2012:  Yuanxin's epigenetic paper with Katrin Chua lab at Stanford is accepted to '''Nature'''. Two years of hard work finally paid off!
 
. 02/2012:  Liguo Wang is offered a '''tenure-track Assistant Professor''' position at Mayo Clinic. Congratulations!
 
. 02/2012:  Justin Park will join us as a Postdoc Associate. Justin will graduate in May with a PhD in Computer Science from Rice University. Welcome!
 
[[Image:Banner.jpg‎‎]]
 
[http://openwetware.org/wiki/Li_Lab:news News Archive]
 
{|width="*"
|
{| style="width: 728px; text-align:center;font-size:12px;font-variant: small-caps;width: 18px; " align="center"
|-


|}




</div>
<br />


|width="30%" style="border: 1px solid #dddddd; color: #000; background-color: #dddddd"|
<br />
<div style="clear: right; text-align: left; float: left; padding: .1em 1.5em .9em; ">
|----
|}
|-
| style="border: 2px dashed #6688aa; background-color:#99CCFF; padding:1em;" valign="top"|


==[http://lilab.openwetware.org/Lab_Members.html:Lab_Members Open Positions]==
<div style="border-bottom: 1px dashed #9999CC;">
Join Dr. Wei Li's lab at Baylor College of Medicine in the Texas Medical Center at Houston, one of the most exciting places in the world for biomedical research!


* Postdoctoral position in Bioinformatics/Computational Biology
Our lab is focused on the design and application of bioinformatics algorithms to elucidate global epigenetic mechanisms and transcription dynamics in normal development and diseases such as cancer. Since establishing the lab in early 2008, we have published more than 50 peer-reviewed papers in high profile journals, such as Nature, Cell, Nature Genetics, Molecular Cell, Genome Research, Genome Biology, Genes and Development, Nucleic Acids Research, Cancer Research, PNAS and Bioinformatics.


We developed a number of widely used algorithms to analyze next generation sequencing data from Chromatin Factor ChIP-seq (MACS, MACE, DyChIPS), DNA Methylation Bisulfite-seq (BSMAP/RRBSMAP, BSeQC, MOABS), Nucleosome Positioning MNase-seq (DANPOS), and RNA-seq (CPAT, RSeQC, DaPars). These algorithms have been broadly adopted by thousands of academic users. For example, the MACS algorithm has gathered >1000 citations since 2008.


* Scientific Programmer position
In collaboration with experimental biologists, we used these algorithms to gain novel biological insights from various biological processes and disease models.


* Chromatin Factors: ER in breast cancer, AR in prostate cancer, FoxA1 pioneer factor, Atoh1 in neuron development, NSD2 in oncogenic programming, SIRT7 in cancer transformation, ZM11 in transcription elongation, and p53 in ES differentiation.


* Multiple openings for graduate students
* DNA Methylation: Dnmt3a in HSC differentiation, DNA methylation Canyon, HSC aging.


* Nucleosome Organization: fragile nucleosome in gene poising, promoter nucleosome with Tup1, nucleosome dynamics in ES differentiation, global nucleosome loss in aging.


* Transcriptome: chimeric RNA in prostate cancer,  Long non-coding RNA in HSC, 3’UTR deletion in cancer and their master regulators.


[http://sites.google.com/a/bcm.edu/lilab/ Lab Intranet]
[http://openwetware.org/wiki/Li_Lab openwetware]
</div>




<div style="border-bottom: 1px dashed #9999CC;">
[[Image:WeiLi.jpg‎]]
</div>
</div>
</div>
 
|}
</center>
<html>
<script type="text/javascript">
 
  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-5924762-2']);
  _gaq.push(['_trackPageview']);
 
  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();
 
</script>
</html>
 
__NOTOC__

Revision as of 14:37, 13 June 2014

Home        People        Publications        Collaborations        Software        Positions        Contact       


Recent News

. 06/2014: Deqiang's Dnmt3a/3b double KO paper (with the Goodell Lab) is accepted to Cell Stem Cell .

. 06/2014: Zheng's alternative splicing paper (with the Cooper Lab) is accepted to Molecular Cell .

. 04/2014: Liguo's ChIP-exo methodology paper (MACE) is accepted in principle in Nucleic Acids Research.

. 02/2014: DQ and HJ's HSC LncRNA paper (with the Goodell Lab) is in revision in Cell Stem Cell.

. 02/2014: Zheng's collaborative work on alternative splicing in heart development is accepted to Nature Communications.

. 02/2014: Zheng's brain tumor 3'UTR regulator paper is accepted to Nature. This paper was initially rejected after review twice. We appealed twice with success and finally made it in the 3rd submission.

. 02/2014: Welcome our new postdoc Jianzhong Su and graduate student Xueqiu Lin.

. 02/2014: Deqiang's mouse HSC Aging Epigenomics paper is accepted in principle to Cell Stem Cell.

. 01/2014: Deqiang's Methodology paper for the detection of differential DNA Methylation (MOABS) is accepted to Genome Biology.

. 01/2014: Our collaborative work on Breast Cancer Epigenetics is accepted to Science Translational Medicine.

. 01/2014: Yuanxin and Zheng's ZM11 paper with Xiaobing Shi lab in MD Anderson is accepted to Nature. This work links transcription elongation to tumor suppression.

. 12/2013: Kaifu's aging nucleosome paper is accepted to Genes & Development

. 12/2013: We received a 5-year NIH/NHGRI R01 grant (scored at 6 percentile in its first submission) to study DNA Methylation

. 11/2013: Wei will serve on the Editorial Board of Molecular Endocrinology

. 09/2013: Deqiang's DNA methylation Canyon paper is accepted to Nature Genetics.

. 09/2013: Xueqiu's bisulfite sequencing quality control paper (BSeQC) is accepted to Bioinformatics.

. 08/2013: Kadir's p53 paper is accepted to Nucleic Acids Research

. 06/2013: Zheng's TCGA RNA-seq bioinformatics paper is under review in Nature Biotechnology.

. 01/2013: BCM News and Epigenie Headline about our recent work on nucleosome dynamics.

. 12/2012: Liguo and HJ's CPAT RNA coding potential prediction paper is accepted to Nucleic Acids Research.

. 11/2012: Kaifu's nucleosome methodology paper DANPOS is accepted to Genome Research.

. 10/2012: Kaifu's promoter nucleosome paper is accepted to Genome Research.

. 09/2012: A NIH R01 grant was funded. We will work with Dr. Issa at Temple Univ. to understand DNA methylation in Cancer.

. 08/2012: A mouse ES nucleosome paper from Kaestner lab at Upenn is accepted to Cell. Kaifu and Wei used DANPOS to analyze the data and were listed as co-authors.

. 08/2012: Dr. Benjamin Rodriguez will join us as a Postdoc Associate. Ben has PhD in Integrated Biomedical Science from the Ohio State Univ. Welcome!

. 08/2012: A Mazzone Award is funded. We will work with Dr. Balk at Harvard Medical School to understand the molecular features of aggressive prostate cancer.

. 06/2012: Liguo's RNA-seq Quality Control paper is accepted to Bioinformatics.

. 06/2012: A NIH R01 grant is funded. We will work with Dr. Goodell at BCM to understand DNA methylation in Hematopoietic Stem Cell.

. 04/2012: A NIH R01 grant is funded. We will work with Dr. Dent at MD Anderson to define USP22 functions during mammalian development.

. 04/2012: Dr.Dean Tang's prostate cancer stem cell paper is accepted in Cell Stem Cell. Wei is a co-author.

. 02/2012: Yuanxin's epigenetic paper with Katrin Chua lab at Stanford is accepted to Nature. Two years of hard work finally paid off!

. 02/2012: Liguo Wang is offered a tenure-track Assistant Professor position at Mayo Clinic. Congratulations!

. 02/2012: Justin Park will join us as a Postdoc Associate. Justin will graduate in May with a PhD in Computer Science from Rice University. Welcome!

News Archive




Our lab is focused on the design and application of bioinformatics algorithms to elucidate global epigenetic mechanisms and transcription dynamics in normal development and diseases such as cancer. Since establishing the lab in early 2008, we have published more than 50 peer-reviewed papers in high profile journals, such as Nature, Cell, Nature Genetics, Molecular Cell, Genome Research, Genome Biology, Genes and Development, Nucleic Acids Research, Cancer Research, PNAS and Bioinformatics.

We developed a number of widely used algorithms to analyze next generation sequencing data from Chromatin Factor ChIP-seq (MACS, MACE, DyChIPS), DNA Methylation Bisulfite-seq (BSMAP/RRBSMAP, BSeQC, MOABS), Nucleosome Positioning MNase-seq (DANPOS), and RNA-seq (CPAT, RSeQC, DaPars). These algorithms have been broadly adopted by thousands of academic users. For example, the MACS algorithm has gathered >1000 citations since 2008.

In collaboration with experimental biologists, we used these algorithms to gain novel biological insights from various biological processes and disease models.

  • Chromatin Factors: ER in breast cancer, AR in prostate cancer, FoxA1 pioneer factor, Atoh1 in neuron development, NSD2 in oncogenic programming, SIRT7 in cancer transformation, ZM11 in transcription elongation, and p53 in ES differentiation.
  • DNA Methylation: Dnmt3a in HSC differentiation, DNA methylation Canyon, HSC aging.
  • Nucleosome Organization: fragile nucleosome in gene poising, promoter nucleosome with Tup1, nucleosome dynamics in ES differentiation, global nucleosome loss in aging.
  • Transcriptome: chimeric RNA in prostate cancer, Long non-coding RNA in HSC, 3’UTR deletion in cancer and their master regulators.


Lab Intranet openwetware


<html> <script type="text/javascript">

 var _gaq = _gaq || [];
 _gaq.push(['_setAccount', 'UA-5924762-2']);
 _gaq.push(['_trackPageview']);
 (function() {
   var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
   ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
   var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
 })();

</script> </html>